Aaron Mendelsohn, J.D.
Mr. Mendelsohn arranges financing as a profession. Within the medical device field, he has been involved in several Al Mann companies assisting in capitalizing MiniMed, MRG, and Advanced Bionics. He is a founder and, since its inception, has been a director for Second Sight Medical Products, a publicly traded company commercializing the world's first prosthetic retina that restores vision to the profoundly blind. He served as a director of MRG from its formation in 1998 until it was sold in 2001 to Medtronic, Inc. for $430M. He served on the board of Advanced Bionics for many years until it was sold to Boston Scientific in 2004. He has served as a director of the Alfred Mann Institute for Biomedical Engineering at USC since its inception in 1998. At that institute, he is a member of the 3-man committee that serves as the CEO. He has served as Chairman of Data Display Products, Inc., a world leader in engineered LED lighting solutions, for over 10 years. He is a founder and has served, since 2007, as a director of Nanoprecision Holding Company, Inc., the world’s leader in manipulating materials at nanometer scale. He is a founder of Mastacopia, S.A., a start-up company founded in 2004, which is developing a new and better method of breast cancer screening.
Mr. Mendelsohn also is a founder and has served as Chairman of the Maestro Foundation since it was organized in 1983. The Maestro foundation is a leading non-profit musical philanthropic organization which hosts what is considered to be the nation’s premier chamber music series and lends approximately 100 professional-level instruments and bows to young, career-bound classical musicians. Mr. Mendelsohn holds a Bachelor’s Degree with honors from UCLA and holds a JD from Loyola University School of Law.